Is it time to revisit R-CHOP for primary CNS lymphoma?
- PMID: 31320363
- DOI: 10.1182/blood.2019001383
Is it time to revisit R-CHOP for primary CNS lymphoma?
Conflict of interest statement
Conflict-of-interest disclosure: T.T.B. has received honoraria from Audio Digest, Oakstone Publishing, UpToDate, NXDC, and Merck and serves on scientific advisory board of Genomicare. L.N. has received honoraria from Bristol-Myers Squibb.
Comment on
-
R-CHOP preceded by blood-brain barrier permeabilization with engineered tumor necrosis factor-α in primary CNS lymphoma.Blood. 2019 Jul 18;134(3):252-262. doi: 10.1182/blood.2019000633. Epub 2019 May 22. Blood. 2019. PMID: 31118164 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials